Recommended Global Immunology Webinars & Conferences

Europe & UK

Cancer Stem Cells 2026, Italy CANCER2026, France Dementia Congress 2026, Netherlands Dermatology-2026, Italy

Asia Pacific & Middle East

Blood Disorders 2026, UAE Neurorehabilitation 2026, UAE Plastic Surgery Conference 2026, UAE traditionalplantmedicine2026, Japan

Canada

INFECTIOUS DISEASES2026, Canada Neonatology_2026, Canada Nutritional 2026, Canada Neurosurgery 2026, Canada

Neuroimmunology Congress 2026

Welcome Message

Dear Participants,

It is our great pleasure to welcome you to the 7th World Congress on Neuroimmunology and Neuroinfectious Diseases, taking place on May 25–26, 2026, in Rome, Italy.

This year’s theme, “Bridging Immunity and Infection in Neurological Health: Innovations and Future Directions,” highlights the critical intersection of immune mechanisms and infectious processes in shaping neurological outcomes. The congress aims to foster collaboration, inspire innovation, and advance our understanding of complex neuroimmunological and neuroinfectious disorders.

We are honored to bring together leading researchers, clinicians, and experts from around the globe to share their latest findings, exchange ideas, and build meaningful connections. Through keynote sessions, panel discussions, and interactive forums, we hope to create a dynamic environment that encourages learning and discovery.

We look forward to your active participation and to an engaging and impactful congress in the historic and inspiring city of Rome.

Warm regards,
Organizing Committee
7th World Congress on Neuroimmunology and Neuroinfectious Diseases

About the Congress

The 7th World Congress on Neuroimmunology and Neuroinfectious Diseases will be held on May 25–26, 2026 in Rome, bringing together leading experts, researchers, clinicians, and healthcare professionals from across the globe.

This international congress serves as a premier platform for sharing cutting-edge research, clinical advancements, and emerging technologies in the fields of neuroimmunology and neuroinfectious diseases. It aims to enhance understanding of the complex interactions between the immune system and the nervous system, as well as the impact of infectious agents on neurological health.

The event will feature keynote lectures, scientific sessions, panel discussions, workshops, and poster presentations covering a wide range of topics such as autoimmune neurological disorders, neuroinflammation, multiple sclerosis, CNS infections, and novel therapeutic strategies.

Participants will benefit from valuable networking opportunities, interdisciplinary collaboration, and exposure to the latest innovations shaping the future of neuroscience and immunology. Conferences like these play a crucial role in advancing knowledge, fostering global partnerships, and improving patient care outcomes in neurological disorders.

Set in the historic and inspiring city of Rome, the congress also offers attendees a unique opportunity to experience rich cultural heritage while engaging in high-level scientific exchange.

Why Attend the Congress

Attending the 7th World Congress on Neuroimmunology and Neuroinfectious Diseases (2026) offers a unique opportunity to stay at the forefront of rapidly evolving research and clinical practice.

Gain latest insights in neuroimmunology and neuroinfectious diseases
Learn from leading global experts and keynote speakers
Network with researchers, clinicians, and industry professionals
Present your research and receive expert feedback
Explore new technologies and innovative treatments
Enhance professional skills and knowledge
Build international collaborations and partnerships
Stay updated with current trends and breakthroughs
Participate in interactive sessions and discussions
Experience the scientific and cultural richness of Rome, Italy

Target Audience

Neurologists
Immunologists
Infectious disease specialists
Neuroscientists and researchers
Physicians and healthcare professionals
Clinical practitioners and surgeons
Epidemiologists
Microbiologists and virologists
Pharmacologists and pharmaceutical professionals
Medical and life science students
Academic faculty and scholars
Public health professionals
Industry experts and medical technology developers
Policy makers and healthcare organizations

Sessions and Tracks

Session 01: Advances in Neuroimmunology and Neuroinflammation

Advances in neuroimmunology continue to reveal the complex interactions between the immune system and the central nervous system, highlighting the critical role of neuroinflammation in neurological disorders such as multiple sclerosis and autoimmune encephalitis. Current research focuses on understanding the cellular and molecular mechanisms involving microglia, astrocytes, and peripheral immune responses that contribute to disease onset and progression. Significant progress has been made in identifying reliable biomarkers for early diagnosis and monitoring, along with the development of advanced imaging techniques that improve clinical assessment. Innovative therapeutic strategies, including immunomodulatory and targeted treatments, are transforming patient care by offering more precise and effective management options. Additionally, the influence of genetic and environmental factors is increasingly recognized in shaping disease susceptibility and outcomes, providing new opportunities for prevention and personalized medicine approaches in neuroimmune disorders.

Session 02: Neuroinfectious Diseases and Global Health Challenges

Neuroinfectious diseases remain a significant global health concern, affecting millions of individuals and posing serious challenges to healthcare systems worldwide. These conditions, caused by a wide range of pathogens including viruses, bacteria, fungi, and parasites, can lead to severe neurological complications such as meningitis, encephalitis, and brain abscesses. Understanding the epidemiology, transmission patterns, and pathophysiology of these infections is essential for effective prevention and management. Recent advancements in diagnostic techniques, including molecular testing and neuroimaging, have improved early detection and accurate identification of infectious agents, while emerging and re-emerging infections along with antimicrobial resistance continue to complicate treatment strategies. Innovative therapeutic approaches, including antiviral and antimicrobial therapies, immunotherapies, and supportive care, are helping improve patient outcomes, alongside public health measures such as vaccination programs and surveillance systems that play a crucial role in reducing disease burden. This session emphasizes the importance of interdisciplinary collaboration to address ongoing challenges and develop effective global strategies for prevention, diagnosis, and treatment.

Session 03: Autoimmune Neurological Disorders and Therapeutic Advances

Autoimmune neurological disorders represent a diverse group of conditions in which the immune system mistakenly attacks components of the nervous system, leading to inflammation and neurological dysfunction. This session will focus on disorders such as multiple sclerosis, neuromyelitis optica spectrum disorder, and autoimmune encephalitis, highlighting their underlying immunopathological mechanisms, clinical manifestations, and diagnostic approaches. Advances in biomarkers, neuroimaging, and laboratory techniques have significantly improved early and accurate diagnosis. The session will also explore recent therapeutic developments, including immunomodulatory drugs, monoclonal antibodies, and personalized medicine approaches aimed at controlling disease activity and preventing relapses. Emphasis will be placed on emerging research trends, clinical case studies, and multidisciplinary strategies that enhance patient management and long-term outcomes.

Session 04: Neurodegeneration and Immune System Interactions

Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis are increasingly recognized to involve complex interactions between the nervous and immune systems. This session will examine the role of chronic inflammation, immune dysregulation, and protein aggregation in driving neurodegeneration and disease progression. Key topics include the involvement of microglial activation, cytokine signaling, and oxidative stress in neuronal damage. Advances in research have identified potential biomarkers for early detection and monitoring of disease progression, as well as novel therapeutic targets aimed at modulating immune responses. The session will also discuss current challenges in treatment, ongoing clinical trials, and future directions in developing disease-modifying therapies that can slow or halt neurodegenerative processes.

Session 05: Emerging Technologies and Future Directions in Neuroimmunology

This session will highlight cutting-edge technologies and innovative approaches that are shaping the future of neuroimmunology and neuroinfectious disease research. Topics will include advances in artificial intelligence, machine learning, and big data analytics for disease prediction and personalized medicine, as well as novel imaging techniques that enhance visualization of neuroimmune processes. The session will also explore breakthroughs in genomics, proteomics, and biomarker discovery that are enabling more precise diagnostics and targeted therapies. In addition, developments in drug delivery systems, gene therapy, and nanotechnology will be discussed for their potential to improve treatment efficacy. By integrating technology with biomedical research, this session aims to provide insights into future trends, challenges, and opportunities that will transform both research and clinical practice in the coming years.

Session 06: Neuroimmunology in Pediatric Disorders

This session focuses on the role of neuroimmunological mechanisms in pediatric neurological disorders, including pediatric multiple sclerosis, autoimmune encephalitis, and neurodevelopmental conditions linked to immune dysfunction. It will explore how immune system abnormalities influence brain development, cognition, and behavior in children. Emphasis will be placed on early diagnosis, age-specific biomarkers, and the challenges of managing neurological diseases in pediatric populations. Advances in pediatric neuroimaging, immunotherapies, and supportive care strategies will also be discussed, along with clinical case studies that highlight diagnosis and treatment complexities in children.

Session 07: CNS Infections: Diagnosis, Management, and Prevention

Central nervous system infections such as meningitis, encephalitis, and brain abscesses remain critical medical emergencies requiring timely diagnosis and intervention. This session will address the latest advancements in diagnostic methods, including PCR-based techniques, cerebrospinal fluid analysis, and neuroimaging tools. It will also cover evidence-based management strategies involving antimicrobial therapies, supportive care, and complication prevention. Preventive measures such as vaccination, infection control practices, and public health policies will be emphasized. The session aims to provide a comprehensive overview of clinical approaches to effectively manage CNS infections and reduce associated morbidity and mortality.

Session 08: Biomarkers and Precision Medicine in Neuroimmune Disorders

Biomarkers play a crucial role in the early detection, prognosis, and treatment monitoring of neuroimmune disorders. This session will highlight recent advancements in identifying molecular, genetic, and imaging biomarkers that support precision medicine approaches. Topics include the use of omics technologies, liquid biopsies, and advanced neuroimaging techniques to improve diagnostic accuracy and personalize treatment strategies. The session will also explore how integrating biomarker data with clinical insights can enhance patient stratification, predict treatment response, and guide targeted therapies. Discussions will focus on translating research findings into clinical practice for improved patient outcomes.

Session 09: Immunotherapy and Novel Treatment Strategies

Immunotherapy has transformed the treatment landscape for various neuroimmunological and neuroinfectious diseases. This session will examine current and emerging immunotherapeutic approaches, including monoclonal antibodies, immune checkpoint modulation, cytokine therapies, and cell-based treatments. It will also discuss novel drug delivery systems and combination therapies aimed at improving efficacy while minimizing side effects. Clinical trials, safety considerations, and treatment challenges will be reviewed to provide a balanced understanding of therapeutic advancements. The session emphasizes innovation in treatment design and the move toward more targeted, patient-specific therapeutic interventions.

Session 10: Translational Research and Clinical Applications in Neuroimmunology

Translational research bridges the gap between laboratory discoveries and clinical practice, playing a vital role in advancing neuroimmunology. This session will focus on how basic science findings are being translated into diagnostic tools, therapeutic strategies, and clinical protocols. It will cover interdisciplinary collaborations, experimental models, and clinical trial design that facilitate the development of new interventions. The session will also highlight success stories where research has led to improved patient care, as well as the challenges faced in translating research into real-world applications. The goal is to encourage integration of research and clinical efforts to accelerate innovation and improve neurological health outcomes.

Session 11: Public Health, Policy, and Global Collaboration in Neuroimmunology

This session will focus on the role of public health strategies, healthcare policies, and international collaboration in addressing neuroimmunological and neuroinfectious diseases. It will explore how governments, healthcare organizations, and global agencies work together to improve disease surveillance, prevention, and control through vaccination programs, awareness campaigns, and early detection initiatives. The session will also examine disparities in healthcare access, the impact of socioeconomic factors on neurological health, and the need for equitable distribution of resources and treatments. In addition, discussions will highlight the importance of global research networks, data sharing, and collaborative frameworks in advancing scientific knowledge and responding effectively to emerging neurological threats. The session aims to provide insights into how coordinated efforts at local, national, and international levels can strengthen healthcare systems and improve outcomes for patients worldwide.

Session 12: Rehabilitation and Long-Term Management of Neuroimmune Disorders

This session will focus on the rehabilitation strategies and long-term management approaches for patients affected by neuroimmune and neuroinfectious disorders. It will cover multidisciplinary rehabilitation methods including physical therapy, occupational therapy, speech and language therapy, and cognitive rehabilitation aimed at improving functional independence and quality of life. The session will also address chronic symptom management, including fatigue, pain, mobility challenges, and cognitive impairments commonly associated with neurological conditions. Emphasis will be placed on individualized care plans, patient-centered approaches, and the role of caregivers in supporting recovery and daily functioning. Additionally, the session will explore advances in assistive technologies, tele-rehabilitation, and long-term follow-up care, highlighting the importance of continuous monitoring, psychosocial support, and holistic management strategies to enhance patient outcomes and overall well-being.

Session 13: Case Studies and Clinical Practice in Neuroimmunology

This session will present a series of real-world case studies highlighting complex and challenging scenarios in the diagnosis and management of neuroimmunological and neuroinfectious diseases. It will provide insights into clinical decision-making processes, differential diagnosis, and the application of evidence-based treatment strategies in diverse patient populations. Experts will discuss atypical presentations, diagnostic dilemmas, and treatment responses, offering practical lessons from clinical experience. The session will also emphasize interdisciplinary collaboration among neurologists, immunologists, infectious disease specialists, and radiologists to achieve accurate diagnosis and effective patient care. By analyzing these cases, participants will gain a deeper understanding of practical challenges, improve clinical reasoning skills, and stay updated on best practices in managing complex neurological conditions.

Session 14: Young Researchers, Innovation, and Emerging Ideas

This session is dedicated to encouraging young researchers, students, and early-career professionals to present their innovative ideas, ongoing research, and novel approaches in the fields of neuroimmunology and neuroinfectious diseases. It provides a platform to showcase original work, receive constructive feedback from experts, and engage in meaningful scientific discussions. The session will highlight emerging concepts, exploratory studies, and cutting-edge methodologies that contribute to advancing knowledge and addressing current challenges in the field. Special emphasis will be placed on fostering creativity, critical thinking, and collaboration among the next generation of scientists and clinicians. By supporting young talent and new perspectives, this session aims to inspire innovation and contribute to the future growth and development of neuroimmunology research and clinical practice.

Session 15: Artificial Intelligence and Data-Driven Approaches in Neuroimmunology

This session will explore the growing role of artificial intelligence (AI), machine learning, and data analytics in advancing research and clinical practice in neuroimmunology and neuroinfectious diseases. It will focus on how large-scale datasets, including clinical records, imaging data, and genomic information, are being leveraged to improve disease prediction, diagnosis, and treatment personalization. The session will highlight AI-driven tools for pattern recognition in neuroimaging, biomarker discovery, and risk stratification, as well as their applications in clinical decision support systems. Discussions will also address challenges such as data quality, ethical considerations, privacy concerns, and the integration of AI technologies into healthcare systems. By bridging computational science with biomedical research, this session aims to showcase how data-driven approaches are transforming the understanding and management of neurological disorders.

Session 16: Ethical Considerations and Future Perspectives in Neuroimmunology Research

This session will address the ethical challenges and responsibilities associated with research and clinical practice in neuroimmunology and neuroinfectious diseases. It will cover topics such as patient consent, data privacy, equitable access to advanced therapies, and the ethical implications of emerging technologies including genetic engineering, AI-driven diagnostics, and experimental treatments. The session will also discuss the importance of maintaining integrity in scientific research, responsible reporting of data, and adherence to regulatory standards in clinical trials. In addition, it will explore future perspectives in the field, including evolving research priorities, global collaboration, and the development of sustainable healthcare models. By examining both ethical frameworks and forward-looking strategies, this session aims to guide researchers and clinicians in making informed, responsible decisions while contributing to the advancement of neuroscience and immunology.

Session 17: Immunogenetics and Neuroimmune Interactions

This session will explore the role of genetic factors in shaping immune responses within the nervous system and their contribution to neuroimmunological and neuroinfectious diseases. It will focus on how variations in genes related to immune regulation influence susceptibility, disease progression, and treatment response in conditions such as multiple sclerosis and other autoimmune neurological disorders. Advances in genome-wide association studies (GWAS), next-generation sequencing, and epigenetic research have provided deeper insights into the genetic architecture underlying these diseases. The session will also examine the interaction between genetic predisposition and environmental triggers, highlighting how these factors collectively impact neuroimmune mechanisms. In addition, emerging approaches in personalized medicine based on genetic profiling will be discussed, emphasizing their potential to improve diagnosis, risk assessment, and targeted therapeutic strategies in clinical practice.

Session 18: Microbiome and the Gut-Brain-Immune Axis

This session will focus on the emerging role of the microbiome in regulating interactions between the gut, brain, and immune system, commonly referred to as the gut-brain-immune axis. It will explore how the composition and diversity of gut microbiota influence immune responses, neuroinflammation, and neurological function. Disruptions in the microbiome have been linked to various neuroimmunological and neuropsychiatric conditions, including multiple sclerosis, autism spectrum disorders, and neurodegenerative diseases. The session will discuss recent advances in microbiome research, including metagenomics, metabolomics, and microbiota-based therapies such as probiotics, prebiotics, and fecal microbiota transplantation. Emphasis will also be placed on understanding the mechanisms through which microbial metabolites affect immune signaling and brain function, as well as the potential for microbiome-targeted interventions in prevention and treatment strategies.

Session 19: Advances in Neuroimaging and Diagnostic Techniques

This session will focus on the latest advancements in neuroimaging and diagnostic methodologies that are enhancing the understanding, detection, and monitoring of neuroimmunological and neuroinfectious diseases. It will cover state-of-the-art imaging modalities such as MRI, PET, and CT scans, along with functional and molecular imaging techniques that provide detailed insights into brain structure and activity. The session will also explore the role of advanced imaging biomarkers in early diagnosis, disease progression tracking, and treatment evaluation. In addition, innovations in imaging analysis using AI and machine learning will be discussed for improved accuracy and efficiency. By integrating imaging technologies with clinical and laboratory data, this session aims to highlight their critical role in supporting precise diagnosis and informed clinical decision-making.

Session 20: Clinical Trials and Drug Development in Neuroimmunology

This session will address the process of clinical trials and the development of new therapeutic agents for neuroimmunological and neuroinfectious diseases. It will provide an overview of trial design, regulatory considerations, patient recruitment, and ethical aspects involved in conducting clinical research. The session will highlight recent advancements in drug development, including biologics, small molecules, and targeted therapies aimed at modulating immune responses and improving neurological outcomes. Challenges such as trial endpoints, safety evaluation, and translational gaps between preclinical and clinical research will also be discussed. Additionally, the session will emphasize the importance of collaboration between academia, industry, and regulatory bodies to accelerate the development and approval of safe and effective treatments for neurological disorders.

Market Analysis Report

Over the past five years (2020–2025), the neuroimmunology and neuroinfectious diseases conference space has shown steady expansion, supported by growing global research activity and increased clinical interest in neurological disorders. The estimated global participation value of this conference segment has grown from approximately US$ 1.2–1.5 billion in 2020 to around US$ 2.0–2.4 billion in 2025, reflecting rising investments in medical conferences, scientific events, and academic networking platforms. The COVID-19 pandemic significantly accelerated the need for knowledge sharing in neuroinfectious diseases, driving increased attendance, virtual participation, and digital transformation of conferences into hybrid formats.

During this period, there has been a consistent rise in the number of international attendees, submissions of scientific abstracts, and collaborations between academia, healthcare institutions, and industry players. Estimated global participation at major neurology and immunology conferences increased by nearly 30–40%, as hybrid events enabled broader accessibility across regions. Additionally, sponsorship revenue and exhibitor engagement also expanded, with an estimated annual growth rate of 6–8%, driven by pharmaceutical companies, biotechnology firms, and medical device manufacturers seeking visibility and collaboration opportunities.

Overall, the past five years have established a strong upward trend in both participation and market value, positioning neuroimmunology and neuroinfectious disease conferences as highly relevant platforms for scientific exchange, innovation, and global collaboration. The integration of virtual technologies, increased research output, and stronger industry involvement have collectively contributed to sustained growth and enhanced global reach of these scientific events.

Associations and Societies

World Federation of Neurology (WFN)
European Academy of Neurology (EAN)
American Academy of Neurology (AAN)
International Society of Neuroimmunology (ISNI)
European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Consortium of Multiple Sclerosis Centers (CMSC)
International Multiple Sclerosis Society (IMSS)
International Society for Neurochemistry (ISN)
Society for Neuroscience (SfN)
International Society for Neuroinfectious Diseases (ISND)
European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Infectious Diseases Society of America (IDSA)
World Health Organization (WHO)
National Institute of Neurological Disorders and Stroke (NINDS)
Alzheimer's Association
Parkinson’s Foundation
Global Alliance for Brain Diseases (GABD)

Participants Benefits

Access to all scientific sessions including Keynotes, Plenary, Workshops, Symposiums, and Poster Presentations
Opportunity to present research through oral and poster presentations
International Organizing Committee Member (IOCM) Certificate for participants
Conference kit including souvenir and final program (e-copies)
Publication of abstracts in conference souvenir and associated international journals
Unique DOI number assigned to each abstract via CrossRef
Networking opportunities with global experts, researchers, and industry leaders
One-on-one interactions and meetings with eminent speakers
Exposure to keynote talks by leading international researchers
Opportunities for academic and industry collaborations
Participation in interactive workshops and symposiums
Recognition through awards such as Best Poster and Outstanding Young Researcher Award
Group registration benefits and discounted participation options
Platform to showcase research innovations and emerging technologies
Enhanced visibility through conference website and global reach
Opportunities for sponsorships, exhibitions, and partnerships
Engagement with decision-makers from universities, hospitals, laboratories, and industries
Professional development and knowledge enhancement in neuroimmunology and neuroinfectious diseases
Access to a global platform for sharing ideas, building collaborations, and advancing research careers

Abstract Submission Guidelines & Deadline

Abstracts must be submitted through the official conference submission portal or designated email.
All abstracts should be written in clear English and follow a structured format (Background, Methods, Results, Conclusion).
The abstract title should be concise and relevant to the topic.
Include author names, affiliations, and contact details of the presenting author.
The abstract should not exceed the specified word limit (typically 250–300 words unless otherwise stated).
Use standard formatting (Times New Roman, font size 11–12, single spacing).
Avoid tables, figures, and references unless explicitly allowed.
Indicate the preferred presentation type (oral/poster) during submission.
All submissions will undergo review by the scientific committee.
Accepted abstracts will be notified via email along with further presentation instructions.

Deadline:
Abstract submission deadline: May 05, 2026

Registration Details

Registration is open to all interested participants including researchers, clinicians, academicians, industry professionals, and students.
Participants can register through the official conference website or designated registration portal.
Early bird registration options are available with discounted fees for timely submissions.
Group registration discounts are offered for institutions and teams registering together.
Registration categories may include: Student, Academic, Delegate, and Industry Participant.
Registration fee typically includes access to all scientific sessions, conference kit, and participation certificate.
Additional benefits may include conference materials, networking opportunities, and access to workshops and symposiums.
Payment can be made through available online payment methods as specified during registration.
Confirmation of registration will be sent via email upon successful payment.
Participants are advised to complete registration before the deadline to avail benefits and ensure participation.
On-site registration may be available subject to seat availability and higher fees.
Cancellation and refund policies, if applicable, will be provided on the official website.

Submit your Abstract here
Register your participation and take the next step in sharing your research with a global audience. Complete your registration through the official conference portal and be part of the 7th World Congress on Neuroimmunology and Neuroinfectious Diseases.

Past Conference Report

Neuroimmunology Congress 2025

Welcome to the 6th World Congress on Neuroimmunology and Neuroinfectious Diseases , taking place from September 22-23, 2025, in the historic city of Amsterdam, Netherland. This premier event gathers leading experts, researchers, and clinicians from around the world to explore the cutting-edge developments in neuroimmunology and neuroinfectious diseases.

The conference theme, "Neuroimmune Biomarkers for Early Detection and Monitoring of Neuroinfectious Diseases," underscores the critical role that biomarkers play in advancing our understanding and treatment of these complex conditions. As neuroinfectious diseases continue to pose significant global health challenges, the ability to detect and monitor them early is paramount. This conference will delve into the latest discoveries and innovations in biomarker research, offering new perspectives on diagnosis, disease progression, and therapeutic interventions.

Neuroimmunology Congress 2025 provides a dynamic platform for exchanging knowledge, fostering collaboration, and driving innovation. Attendees can expect a comprehensive program that includes keynote addresses from world-renowned speakers, cutting-edge research presentations, interactive workshops, and panel discussions. These sessions will cover a broad range of topics, from the molecular mechanisms of neuroimmune interactions to the application of precision medicine in managing neuroinfectious diseases.

Participants will have the opportunity to network with peers, share their latest research findings, and explore potential collaborations that could shape the future of neuroimmunology. Whether you are a seasoned expert or a young researcher, this congress offers a unique opportunity to engage with the latest scientific advancements and contribute to the global effort to combat neuroinfectious diseases.

Join us in Rome, a city rich in history and culture, as we work together to push the boundaries of neuroimmunology and improve patient outcomes worldwide. We look forward to welcoming you to an unforgettable and intellectually stimulating experience at Neuroimmunology Congress 2025.

Past Reports Gallery

To Collaborate Scientific Professionals around the World

Conference Date May 25-26, 2026

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Neuroimmunology Congress 2025 Conference

Supported By

Journal of Neurological Disorders International Journal of Neurorehabilitation Journal of Neurology & Neurophysiology Abstracts will be provided with Digital Object Identif

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Neuroimmunology and Neuroinfectious Diseases

May 25-26, 2026 Rome, Italy

Bridging Immunity and Infection in Neurological Health: Innovations and Future Directions

Conference Series Conferences gaining more Readers and Visitors

Recommended Global Immunology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Neuroimmunology Congress 2026

Welcome Message

About the Congress

Why Attend the Congress

Target Audience

Sessions and Tracks

Market Analysis Report

Participants Benefits

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By

Keytopics